首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Journal Of Clinical Pharmacology

Journal Of Clinical Pharmacology杂志,由Wiley-Blackwell出版,于1973年创刊,Monthly,出版语言English,ISSN:1552-4604,E-ISSN:1552-4604。

投稿咨询
Journal Of Clinical Pharmacology
Journal Of Clinical Pharmacology
Journal Of Clinical Pharmacology
SCI SCIE

杂志介绍

JCR分区
Q3
中科院分区
3区
影响因子
2.2
CiteScore
4.7
期刊收录
SCI、SCIE

Journal Of Clinical Pharmacology(中文译名:《临床药理学杂志》),ISSN:1552-4604,EISSN:1552-4604,是Wiley-Blackwell出版的国际性学术期刊,创刊于1973年,以Monthly形式稳定发行,2026年总发文量约138篇。该刊采用非OA开放访问,学科归属为PHARMACOLOGY & PHARMACY。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.2,2025年期刊CiteScore为4.7,2025年期刊自引率约4.5%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Journal Of Clinical Pharmacology长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期约2月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAGERMANY (FED REP GER)、England、Japan、Switzerland、CHINA MAINLAND、Netherlands等为核心发文国家与地区;US FOOD & DRUG ADMINISTRATION (FDA)PFIZER、STATE UNIVERSITY SYSTEM OF FLORIDA、CHILDREN'S NATIONAL HEALTH SYSTEM、MERCK & COMPANY、ABBVIE、AMER COLL CLIN PHARMACOL等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 231 / 356

35.3

学科:PHARMACOLOGY & PHARMACY SCIE Q3 197 / 356

44.8

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 188 / 354

47

学科:PHARMACOLOGY & PHARMACY SCIE Q2 168 / 354

52.68


中国学者近期发文

1
Optimizing Linezolid Dosing in Lung Transplant Recipients: Population Pharmacokinetics, Target Attainment, and Thrombocytopenia Risk Assessmen

Author:Zhang, Dan; Du, Wenwen; Li, Pengmei; Chen, Wenqian; Wang, Xiaoxing

Journal: JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. 66, Issue 2, pp. -. DOI: 10.1002/jcph.70153

2
Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Secukinumab: Dose Exploration in Pediatric Patients with Plaque Psoriasi

Author:Liu, Zhiwei; Wang, Wenhui; Chen, Tao; Li, Yiming; Chen, Youjun; Wu, Yating; Li, Saiya; Xie, Haitang

Journal: JOURNAL OF CLINICAL PHARMACOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/jcph.70056

3
Optimizing Zanubrutinib Dosing in Patients: A PBPK-BO Model Approach to Drug-Drug Interactions and Patients with Hepatic Impairmen

Author:Ren, Jiawei; Shan, Dan; Yue, Guijuan; He, Qiang

Journal: JOURNAL OF CLINICAL PHARMACOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/jcph.70042

4
Can Methotrexate Monotherapy Achieve Clinical Remission in Patients with Active Rheumatoid Arthritis? A Model-Based Meta-Analysi

Author:Chen, Shengyang; Wu, Yangrui; Huang, Wei; Zhou, Jianxing; Wei, Zipeng; Wu, Xuemei

Journal: JOURNAL OF CLINICAL PHARMACOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/jcph.70039

5
The Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Orally Dosed QY201, a Novel JAK1/TYK2 Inhibitor, in Chinese Healthy Subject

Author:Wang, Jia-ying; Gao, Ying-hui; Ruan, Zou-rong; Yang, Dan-dan; Li, Hua; Qiao, Shi-da; Li, Jian-hui; You, Xin; Shi, Jun; Jiang, Bo

Journal: JOURNAL OF CLINICAL PHARMACOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/jcph.70053

6
Once- Versus Twice-Daily Tacrolimus Therapy: Does Improved Adherence Lead to Better Efficacy?-A Pharmacokinetic Perspectiv

Author:Dai, Zi-yan; Han, Lu; Wang, Juan; Liu, Xiao-qin; Chen, Rui; Jiao, Zheng

Journal: JOURNAL OF CLINICAL PHARMACOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/jcph.70021

7
Quantifying the Effect of Posaconazole on Venetoclax Metabolism in Chinese Patients with Hematologic Disease

Author:Sun, Wenli; Wang, Lei; He, Hai; Wang, Gen; Li, Meng; Xue, Yang; Xing, Jing; Cheng, Jian; Liu, Hongxing

Journal: JOURNAL OF CLINICAL PHARMACOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/jcph.70025

8
Population Pharmacokinetics of Fruquintinib, a Selective Oral Inhibitor of VEGFR-1,-2, and-3, in Patients with Refractory Metastatic Colorectal Cance

Author:Zhou, Xiaofei; Yang, Xiaoyan; Grinshpun, Boris; Taylor, Adekemi; Strong, Laura; Dasari, Arvind; Wang-Gillam, Andrea; Li, Jin; Xu, Rui-Hua; Gupta, Neeraj; Chien, Caly

Journal: JOURNAL OF CLINICAL PHARMACOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/jcph.70001

9
Drug-Drug Interaction Between Rifampicin and Albuvirtide: A Phase 1, Randomized, Open-Label Stud

Author:Zhang, Li; Chen, Jun; Lin, Xiao-Yan; Lu, Yan; Wu, Yan; Wu, Yi-Jun; Meng, Xian-Min

Journal: JOURNAL OF CLINICAL PHARMACOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/jcph.6191


在线咨询

Journal Of Clinical Pharmacology

国际简称:J CLIN PHARMACOL参考译名:临床药理学杂志

年发文量:138 CiteScore:4.7 是否预警:否 Gold OA文章占比:32.10% 研究类文章占比:91.30%

杂志社联系方式:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774

Journal Of Clinical Pharmacology